Cargando…

Implementing prescribing safety indicators in prisons: A mixed methods study

AIMS: To examine the prevalence of potentially hazardous prescribing in the prison setting using prescribing safety indicators (PSIs) and explore their implementation and use in practice. METHODS: PSIs were identified and reviewed by the project team following a literature review and a nominal group...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuzour, Aseel S., Magola‐Makina, Esnath, Dunlop, James, O'Brien, Amber, Khawagi, Wael Y., Ashcroft, Darren M., Brown, Petra, Keers, Richard N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297974/
https://www.ncbi.nlm.nih.gov/pubmed/34625991
http://dx.doi.org/10.1111/bcp.15107
_version_ 1784750594904293376
author Abuzour, Aseel S.
Magola‐Makina, Esnath
Dunlop, James
O'Brien, Amber
Khawagi, Wael Y.
Ashcroft, Darren M.
Brown, Petra
Keers, Richard N.
author_facet Abuzour, Aseel S.
Magola‐Makina, Esnath
Dunlop, James
O'Brien, Amber
Khawagi, Wael Y.
Ashcroft, Darren M.
Brown, Petra
Keers, Richard N.
author_sort Abuzour, Aseel S.
collection PubMed
description AIMS: To examine the prevalence of potentially hazardous prescribing in the prison setting using prescribing safety indicators (PSIs) and explore their implementation and use in practice. METHODS: PSIs were identified and reviewed by the project team following a literature review and a nominal group discussion. Pharmacists at 2 prison sites deployed the PSIs using search protocols within their electronic health record. Prevalence rates and 95% confidence intervals (CIs) were generated for each indicator. Semi‐structured interviews with 20 prison healthcare staff across England and Wales were conducted to explore the feasibility of deploying and using PSIs in prison settings. RESULTS: Thirteen PSIs were successfully deployed mostly comprising drug–drug interactions (n = 9). Five yielded elevated prevalence rates: use of anticholinergics if aged ≥65 years (Site B: 25.8% [95%CI: 10.4–41.2%]), lack of antipsychotic monitoring for >12 months (Site A: 39.1% [95%CI: 27.1–52.1%]; Site B: 28.6% [95%CI: 17.9–41.4%]), prolonged use of hypnotics (Site B: 46.3% [95%CI: 35.6–57.1%]), antiplatelets prescribed with nonsteroidal anti‐inflammatory drugs without gastrointestinal protection (Site A: 12.5% [95%CI: 0.0–35.4%]; Site B: 16.7% [95%CI: 0.4–64.1%]), and selective serotonin/norepinephrine reuptake inhibitors prescribed with nonsteroidal anti‐inflammatory drugs/antiplatelets without gastrointestinal protection (Site A: 39.6% [95%CI: 31.2–48.4%]; Site B: 33.3% [95%CI: 20.8–47.9%]). Prison healthcare staff supported the use of PSIs and identified key considerations to guide its successful implementation, including staff engagement and PSI 'champions'. To respond to PSI searches, stakeholders suggested contextualised patient support through intraprofessional collaboration. CONCLUSION: We successfully implemented a suite of PSIs into 2 prisons, identifying those with higher prevalence values as intervention targets. When appropriately resourced and integrated into staff workflow, PSI searches may support prescribing safety in prisons.
format Online
Article
Text
id pubmed-9297974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92979742022-07-21 Implementing prescribing safety indicators in prisons: A mixed methods study Abuzour, Aseel S. Magola‐Makina, Esnath Dunlop, James O'Brien, Amber Khawagi, Wael Y. Ashcroft, Darren M. Brown, Petra Keers, Richard N. Br J Clin Pharmacol Original Articles AIMS: To examine the prevalence of potentially hazardous prescribing in the prison setting using prescribing safety indicators (PSIs) and explore their implementation and use in practice. METHODS: PSIs were identified and reviewed by the project team following a literature review and a nominal group discussion. Pharmacists at 2 prison sites deployed the PSIs using search protocols within their electronic health record. Prevalence rates and 95% confidence intervals (CIs) were generated for each indicator. Semi‐structured interviews with 20 prison healthcare staff across England and Wales were conducted to explore the feasibility of deploying and using PSIs in prison settings. RESULTS: Thirteen PSIs were successfully deployed mostly comprising drug–drug interactions (n = 9). Five yielded elevated prevalence rates: use of anticholinergics if aged ≥65 years (Site B: 25.8% [95%CI: 10.4–41.2%]), lack of antipsychotic monitoring for >12 months (Site A: 39.1% [95%CI: 27.1–52.1%]; Site B: 28.6% [95%CI: 17.9–41.4%]), prolonged use of hypnotics (Site B: 46.3% [95%CI: 35.6–57.1%]), antiplatelets prescribed with nonsteroidal anti‐inflammatory drugs without gastrointestinal protection (Site A: 12.5% [95%CI: 0.0–35.4%]; Site B: 16.7% [95%CI: 0.4–64.1%]), and selective serotonin/norepinephrine reuptake inhibitors prescribed with nonsteroidal anti‐inflammatory drugs/antiplatelets without gastrointestinal protection (Site A: 39.6% [95%CI: 31.2–48.4%]; Site B: 33.3% [95%CI: 20.8–47.9%]). Prison healthcare staff supported the use of PSIs and identified key considerations to guide its successful implementation, including staff engagement and PSI 'champions'. To respond to PSI searches, stakeholders suggested contextualised patient support through intraprofessional collaboration. CONCLUSION: We successfully implemented a suite of PSIs into 2 prisons, identifying those with higher prevalence values as intervention targets. When appropriately resourced and integrated into staff workflow, PSI searches may support prescribing safety in prisons. John Wiley and Sons Inc. 2021-10-29 2022-04 /pmc/articles/PMC9297974/ /pubmed/34625991 http://dx.doi.org/10.1111/bcp.15107 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Abuzour, Aseel S.
Magola‐Makina, Esnath
Dunlop, James
O'Brien, Amber
Khawagi, Wael Y.
Ashcroft, Darren M.
Brown, Petra
Keers, Richard N.
Implementing prescribing safety indicators in prisons: A mixed methods study
title Implementing prescribing safety indicators in prisons: A mixed methods study
title_full Implementing prescribing safety indicators in prisons: A mixed methods study
title_fullStr Implementing prescribing safety indicators in prisons: A mixed methods study
title_full_unstemmed Implementing prescribing safety indicators in prisons: A mixed methods study
title_short Implementing prescribing safety indicators in prisons: A mixed methods study
title_sort implementing prescribing safety indicators in prisons: a mixed methods study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297974/
https://www.ncbi.nlm.nih.gov/pubmed/34625991
http://dx.doi.org/10.1111/bcp.15107
work_keys_str_mv AT abuzouraseels implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT magolamakinaesnath implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT dunlopjames implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT obrienamber implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT khawagiwaely implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT ashcroftdarrenm implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT brownpetra implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy
AT keersrichardn implementingprescribingsafetyindicatorsinprisonsamixedmethodsstudy